The US Food and Drug Administration (FDA) has approved Infilbray (venglustat) for the treatment of neurological manifestations of Gaucher disease type 3 (GD3) in adults and pediatric patients weighing at least 15 kg. GD is a genetic lysosomal disordercaused by genetic...














Pimicotinib in Tenosynovial Giant Cell Tumor
CheckRare 8 hours ago